1. EMA's improved EudraVigilance system launched

   News item 09 December 2017 Pages: 1 - 1

2. Information for codeine products in Australia updated

   News item 09 December 2017 Pages: 2 - 2

3. MHRA: prescribe, dispense oral tacrolimus by brandname only

   News item 09 December 2017 Pages: 3 - 3

4. Quinine: reminder of QT-prolonging effects + interactions

   News item 09 December 2017 Pages: 4 - 4

5. Warnings of histamine-related ADRs with gentamicin

   News item 09 December 2017 Pages: 5 - 5

6. WHO report on substandard or falsified medicines

   News item 09 December 2017 Pages: 6 - 6

7. Abnormal behaviour warnings with flu antivirals in Japan

   News item 09 December 2017 Pages: 7 - 7

8. Automated algorithm to detect adverse drug reaction signals

   Clinical study 09 December 2017 Pages: 8 - 8

9. Long-term adalimumab adverse event profile

   Clinical study 09 December 2017 Pages: 9 - 9

10. Lower-limb amputations with empagliflozin

    Clinical study 09 December 2017 Pages: 10 - 10

11. Medication errors in academic medical centre increase costs

    Clinical study 09 December 2017 Pages: 11 - 11

12. PCSK9 inhibitors: drug safety prediction using gene variants

    Clinical study 09 December 2017 Pages: 12 - 12

13. Safety information reporting for biosimilars and originators

    Clinical study 09 December 2017 Pages: 13 - 13

14. Acenocoumarol/dabigatran etexilate

    Case report 09 December 2017 Pages: 14 - 14

15. Adalimumab

    Case report 09 December 2017 Pages: 15 - 15

16. Adalimumab

    Case report 09 December 2017 Pages: 16 - 16

17. Adalimumab/infliximab

    Case report 09 December 2017 Pages: 17 - 17

18. Adalimumab/mercaptopurine

    Case report 09 December 2017 Pages: 18 - 18

19. Afatinib/erlotinib/osimertinib

    Case report 09 December 2017 Pages: 19 - 19

20. Alemtuzumab

    Case report 09 December 2017 Pages: 20 - 20

21. Alemtuzumab

    Case report 09 December 2017 Pages: 21 - 21

22. Alemtuzumab

    Case report 09 December 2017 Pages: 22 - 22

23. Alemtuzumab

    Case report 09 December 2017 Pages: 23 - 23

24. Alemtuzumab

    Case report 09 December 2017 Pages: 24 - 24

25. Alemtuzumab

    Case report 09 December 2017 Pages: 25 - 25

26. Alemtuzumab

    Case report 09 December 2017 Pages: 26 - 26

27. Alemtuzumab

    Case report 09 December 2017 Pages: 27 - 27

28. Alemtuzumab

    Case report 09 December 2017 Pages: 28 - 28

29. Alemtuzumab

    Case report 09 December 2017 Pages: 29 - 29

30. Alemtuzumab

    Case report 09 December 2017 Pages: 30 - 30

31. Alemtuzumab

    Case report 09 December 2017 Pages: 31 - 31

32. Alemtuzumab

    Case report 09 December 2017 Pages: 32 - 32

33. Alemtuzumab

    Case report 09 December 2017 Pages: 33 - 33

34. Alemtuzumab

    Case report 09 December 2017 Pages: 34 - 34

35. Alemtuzumab

    Case report 09 December 2017 Pages: 35 - 35

36. Alemtuzumab

    Case report 09 December 2017 Pages: 36 - 36

37. Alemtuzumab

    Case report 09 December 2017 Pages: 37 - 37

38. Alemtuzumab

    Case report 09 December 2017 Pages: 38 - 38

39. Alemtuzumab

    Case report 09 December 2017 Pages: 39 - 39

40. Alemtuzumab/natalizumab

    Case report 09 December 2017 Pages: 40 - 40

41. Allopurinol abuse

    Case report 09 December 2017 Pages: 41 - 41

42. Allopurinol/azathioprine

    Case report 09 December 2017 Pages: 42 - 42

43. Alteplase

    Case report 09 December 2017 Pages: 43 - 43

44. Alteplase

    Case report 09 December 2017 Pages: 44 - 44

45. Alteplase/heparin/warfarin

    Case report 09 December 2017 Pages: 45 - 45

46. Amfetamine/dexamfetamine

    Case report 09 December 2017 Pages: 46 - 46

47. Amikacin

    Case report 09 December 2017 Pages: 47 - 47

48. Aminophylline

    Case report 09 December 2017 Pages: 48 - 48

49. Amiodarone

    Case report 09 December 2017 Pages: 49 - 49

50. Amlodipine/carvedilol/lipid emulsion

    Case report 09 December 2017 Pages: 50 - 50